Jay R. Campbell
Director/Miembro de la Junta en Update Pharma, Inc. .
Perfil
Jay R.
Campbell is currently a Director at Update Pharma, Inc. He previously worked as a Senior Development-Business Development at Kolltan Pharmaceuticals, Inc. and as a Chief Business Officer & VP-Investor Relations at Immutep Ltd.
He completed his undergraduate degree at Bucknell University.
Cargos activos de Jay R. Campbell
| Empresas | Cargo | Inicio |
|---|---|---|
Update Pharma, Inc.
 Update Pharma, Inc. Medical DistributorsDistribution Services Part of MDM Permian, Inc., Update Pharma, Inc. develops and provides anti-cancer drugs and other pharmaceutical products. The American company was founded by William James Garner. Update Pharma was acquired by BestnPet, Inc. on September 09, 2013. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Jay R. Campbell.
| Empresas | Cargo | Fin |
|---|---|---|
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Corporate Officer/Principal | - |
| IMMUTEP LIMITED | Contacto de Relaciones con Inversores | - |
Formación de Jay R. Campbell.
| Bucknell University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| IMMUTEP LIMITED | Health Technology |
| Empresas privadas | 2 |
|---|---|
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
Update Pharma, Inc.
Update Pharma, Inc. Medical DistributorsDistribution Services Part of MDM Permian, Inc., Update Pharma, Inc. develops and provides anti-cancer drugs and other pharmaceutical products. The American company was founded by William James Garner. Update Pharma was acquired by BestnPet, Inc. on September 09, 2013. | Distribution Services |
- Bolsa de valores
- Insiders
- Jay R. Campbell